CDC Division of Parasitic Diseases and Malaria strategic priorities 2021–2025
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields



Publication Date Range:


Document Data


Document Type:






Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page


CDC Division of Parasitic Diseases and Malaria strategic priorities 2021–2025

Filetype[PDF-5.59 MB]

Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
  • English

  • Details:

    • Description:
      CDC’s Division of Parasitic Diseases and Malaria (DPDM) is guided by the same strategic framework that drives all of CDC’s activities: use science and innovation to prevent, detect, and respond to public health threats.

      Within that broad framework, DPDM focuses on diseases caused by parasites, including malaria, cyclosporiasis, Chagas disease, and other neglected tropical diseases (NTDs), among dozens of others.

      Spread by the bite of an infected mosquito, triatomine bug, or blackfly, or perhaps from eating contaminated produce or passed from a mother to her baby, parasitic diseases are responsible for an enormous global burden of illness, disability, and death. In 2019, there were 229 million new malaria infections worldwide and 409,000 deaths, many of those children under five years of age. NTDs, including onchocerciasis, trachoma, and lymphatic filariasis (LF), affect more than one billion people globally.

      However, despite their burden on global health, parasitic diseases are often overlooked or are not well known.

      DPDM serves as the country’s—and often the world’s—last resort when it comes to parasitic disease diagnosis and treatment. When U.S. states or other countries lack the capacity to diagnose a rarely seen parasitic disease such as cysticercosis or African trypanosomiasis, they rely on DPDM to make the proper diagnosis. Just as important as getting the diagnoses right are DPDM’s efforts to educate public health partners, healthcare providers, and the American people about the risks posed by parasitic diseases.

      Our Strategic Priorities for 2021–2025 will help guide DPDM’s core activities that are essential for the control of parasitic diseases in the United States and around the world. For the next four years, DPDM will prioritize activities that build on past and current achievements to maximize our impact.


      Publication date from document properties.


    • Content Notes:
      Background and Introduction -- Vision, Mission, and Values -- Strategic Goals: Strategic Goal 1: Ensure prevention, diagnosis, and treatment of parasitic diseases in the United States; Strategic Goal 2: Reduce the Global Burden of Malaria; Strategic Goal 3: Reduce the Global Burden of Neglected Tropical Diseases (NTDs) -- The United States and Global Health Context.
    • Document Type:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at